Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis

Authors: April W. Armstrong, Ahmed M. Soliman, Paolo Gisondi, Siran Fang, Manish Patel, Bruce Strober

Source: Dermatology and Therapy, Vol 14, Iss 11, Pp 3071-3081 (2024)

Subject Terms: Deucravacitinib, Matching-adjusted indirect comparison, Plaque psoriasis, Risankizumab, Dermatology, RL1-803

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8210; https://doaj.org/toc/2190-9172

Access URL: https://doaj.org/article/4674a01da9764f109764140e3aba0925

Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry

Authors: Bruce Strober, Kristina Callis Duffin, Mark Lebwohl, Adam Sima, Jud Janak, Manish Patel, Huzefa Photowala, Vishvas Garg, Jerry Bagel

Source: Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)

Subject Terms: Psoriasis, quality of life, disease severity, registry, Dermatology, RL1-803

File Description: electronic resource

Relation: https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753

Access URL: https://doaj.org/article/1b0eb84475ce4aa5a48cca6c2ff2e91c

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

Authors: Neil J. Korman, Richard B. Warren, Jerry Bagel, April W. Armstrong, Melinda Gooderham, Bruce Strober, Diamant Thaçi, Akimichi Morita, Shinichi Imafuku, Peter Foley, Howard Sofen, Min Zheng, Lauren Hippeli, Renata M. Kisa, Subhashis Banerjee, Andrew Blauvelt

Source: Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)

Subject Terms: Clinical trials, deucravacitinib, maintenance of response, onset of action, phase 3, psoriasis, Dermatology, RL1-803

File Description: electronic resource

Relation: https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753

Access URL: https://doaj.org/article/565ff6e9db3f40f3996833c3bba76026

Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case series

Authors: Neda Shahriari, MD, Bruce Strober, MD, PhD, Mona Shahriari, MD

Source: JAAD Case Reports, Vol 49, Iss , Pp 106-109 (2024)

Subject Terms: dermatitis, eczema, JAK-STAT pathway, psoriasis, psoriasiform, spongiotic, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352512624001875; https://doaj.org/toc/2352-5126

Access URL: https://doaj.org/article/e036b17a59624a45ab6769ab5b652352

Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry

Authors: Jonathan I. Silverberg, MD, PhD, MPH, Angel Cronin, MS, Eric A. Jones, PhD, MPH, Swapna S. Dave, MPH, MBBS, Robert R. McLean, DSc, MPH, Jeffrey Greenberg, MD, MPH, Bruce Strober, MD, PhD, Thomas Bieber, MD, PhD, MDRA, Melinda Gooderham, MSc, MD, Amy S. Paller, MD, Eric L. Simpson, MD

Source: JAAD International, Vol 15, Iss , Pp 127-130 (2024)

Subject Terms: atopic dermatitis, biologic therapy, biologics, outcomes, QoL, quality of life, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666328724000191; https://doaj.org/toc/2666-3287

Access URL: https://doaj.org/article/4aa74d6d47df4db780c150abfeeb072f

Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry

Authors: Mark Lebwohl, Bruce Strober, Amy Schrader, Alvin H. Li, Thomas Eckmann, Baojin Zhu, William N. Malatestinic, Julie Birt, Meghan Feely, Andrew Blauvelt

Source: Drugs - Real World Outcomes, Vol 11, Iss 3, Pp 451-464 (2024)

Subject Terms: Therapeutics. Pharmacology, RM1-950, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://doaj.org/toc/2199-1154; https://doaj.org/toc/2198-9788

Access URL: https://doaj.org/article/5609bda68fd54de38cb6383ba4e84d38

A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasis

Authors: Benjamin D. Ehst, Bruce Strober, Andrew Blauvelt, Douglas Maslin, Debbie Macaro, Nancy Carpenter, Mark Bodmer, Duncan McHale

Source: Frontiers in Medicine, Vol 11 (2024)

Subject Terms: immunomodulation of skin, Prevotella, EDP1815, psoriasis, phase 2 clinical trial, small intestinal mucosa, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2024.1292406/full; https://doaj.org/toc/2296-858X

Access URL: https://doaj.org/article/5fd2330275af40a3a093c784b86539ee

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

Authors: Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-Le-Bagousse, Bruno Martins, Eric Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober

Source: Dermatology and Therapy, Vol 13, Iss 9, Pp 2107-2120 (2023)

Subject Terms: Atopic dermatitis, Disease control, Dupilumab, Health-related quality of life, Long-term treatment response, Patient-reported outcomes, Dermatology, RL1-803

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8210; https://doaj.org/toc/2190-9172

Access URL: https://doaj.org/article/9c4b20f1602140c1a7be819692ae577c

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients

Authors: Neda Shahriari, MD, Bruce Strober, MD, PhD, Mona Shahriari, MD

Source: JAAD Case Reports, Vol 33, Iss , Pp 81-83 (2023)

Subject Terms: atopic dermatitis, dupilumab, JAK inhibition, tofacitinib, upadactinib, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352512623000334; https://doaj.org/toc/2352-5126

Access URL: https://doaj.org/article/6cbc4f24a6d54ed484b6fa18d4472fab

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Authors: Lars E. Kristensen, Bruce Strober, Denis Poddubnyy, Ying-Ying Leung, Hyejin Jo, Kenneth Kwok, Ivana Vranic, Dona L. Fleishaker, Lara Fallon, Arne Yndestad, Dafna D. Gladman

Source: Therapeutic Advances in Musculoskeletal Disease, Vol 15 (2023)

Subject Terms: Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1759-7218

Access URL: https://doaj.org/article/a4fdb740116042e0a5f1302e3f61e5d5

Treatment of refractory dissecting cellulitis of the scalp with guselkumab: Case report

Authors: Sonal Muzumdar, Sonal Parikh, Bruce Strober

Source: Journal of Dermatology and Dermatologic Surgery, Vol 24, Iss 1, Pp 52-53 (2020)

Subject Terms: dissecting cellulitis of the scalp, guselkumab, hidradenitis suppurativa, Dermatology, RL1-803

File Description: electronic resource

Relation: http://www.jddsjournal.org/article.asp?issn=2352-2410;year=2020;volume=24;issue=1;spage=52;epage=53;aulast=Muzumdar; https://doaj.org/toc/2352-2410; https://doaj.org/toc/2352-2429

Access URL: https://doaj.org/article/e8def2ebc08d4e49bae35ae5dca25e7b

This result is not displayed to guests.
Login for full access.